Aktis Oncology Inc.
AKTS | NASDAQ
$15.27
-$0.66 (-4.14%)
Nov 2, 2026, 9:58 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
PE Ratio | -18.82 | -17.78 | -27.32 | -43.92 |
PEG Ratio | 3.39 | -0.33 | -0.45 | n/a |
PS Ratio | 181.08 | 525.20 | n/a | n/a |
PB Ratio | -8.05 | -8.89 | -16.87 | -40.61 |
P/FCF Ratio | -15.96 | 65.63 | -23.13 | -38.22 |
P/OCF Ratio | -18.35 | 52.90 | -26.03 | -43.09 |
OCF/S Ratio | -987.02 | 992.74 | n/a | n/a |
Debt / Equity Ratio | -0.08 | -0.14 | -0.29 | -0.09 |
Quick Ratio | 7.37 | 15.98 | 16.07 | 25.11 |
Current Ratio | 7.37 | 15.98 | 16.07 | 25.11 |
Asset Turnover | 0.02 | 0 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity | 43.61% | 50.09% | 61.85% | 93.23% |
Return on Assets | -24.06% | -13.48% | -23.41% | -12.96% |
Return on Invested Capital | -31.79% | -16.86% | -29.58% | -14.76% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | n/a | n/a |
Net Profit Margin | -980.93% | -2.96K% | n/a | n/a |
Pretax Profit Margin | -980.93% | -2.96K% | n/a | n/a |
Operating Profit Margin | -1.15K% | -3.5K% | n/a | n/a |
FCF Margin | -1.13K% | 800.27% | n/a | n/a |
EBITDA Margin | -945.08% | -2.85K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AKTS